The FDA on Thursday promised to start posting its drug rejection letters shortly after they're issued to the pharmaceutical companies sponsoring the products. The agency also published 89 of the ...
FDA leaders claimed that publishing hundreds of complete response letters (CRLs) in a central database was embracing "radical transparency," but critics think the move was more about optics, and argue ...
David is managing director at the consulting firm Pharmagellan and professor of the practice in the Tufts University Department of Biology. The U.S. Food and Drug Administration was slammed recently ...
The U.S. Food and Drug Administration (FDA) has unveiled a sweeping transparency initiative that will fundamentally change how innovative drug and biologic developers interface with the Agency and the ...
Every parent believes that feeding their child something as simple as lettuce is safe. We didn’t think twice about it. We shouldn’t have to. But for my family – and too many others – that assumption ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning morning. Today, we learn the FDA is committing to CRL transparency, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results